Evolus reported earnings of -$ 0.09 per EOLS share on Nov 4, 2026, beating analysts' expectations by
| Report Date | Nov 4, 2026 |
|---|---|
| Forecasted EPS | -$ 0.06 |
| Earnings Per Share (Surprise) | -$ 0.09 (-$ 0.03) |
| Last Year's EPS | -$ 0.13 |
| EPS YoY Change |
Out of the last 43 earnings reporting periods, Evolus beat analysts’ expectations 17 times and fell short of expectations 18 time(s). Evolus reported earnings per share of -$ 0.09 in the last report falling to reach an estimated EPS of -$ 0.06 by
| Report Date | Forecasted EPS | Reported EPS | Last Year's EPS | EPS YoY Change |
|---|---|---|---|---|
| Nov 4, 2026 | -$ 0.06 | -$ 0.09 | -$ 0.14 | |
| Aug 5, 2026 | -$ 0.03 | $ 0.00743 | -$ 0.24 | |
| May 4, 2026 | -$ 0.14 | -$ 0.10 | -$ 0.18 | |
| Mar 3, 2026 | $ 0.06 | $ 0.04422 | $ 0.01 | |
| Nov 5, 2025 | -$ 0.19 | -$ 0.14 | -$ 0.19 | |
| Aug 5, 2025 | -$ 0.09 | -$ 0.24 | -$ 0.07 | |
| May 7, 2025 | -$ 0.10 | -$ 0.18 | -$ 0.13 | |
| Mar 4, 2025 | $ 0.02 | $ 0.01 | -$ 0.14 | |
| Nov 6, 2024 | -$ 0.08 | -$ 0.19 | -$ 0.19 | |
| Jul 31, 2024 | -$ 0.04 | -$ 0.07 | -$ 0.22 | |
| May 7, 2024 | -$ 0.15 | -$ 0.13 | -$ 0.17 | |
| Mar 7, 2024 | -$ 0.07 | -$ 0.14 | -$ 0.16 | |
| Nov 7, 2023 | -$ 0.22 | -$ 0.19 | -$ 0.32 | |
| Aug 2, 2023 | -$ 0.22 | -$ 0.22 | -$ 0.38 | |
| May 9, 2023 | -$ 0.13 | -$ 0.17 | -$ 0.27 | |
| Mar 8, 2023 | -$ 0.14 | -$ 0.16 | -$ 0.29 | |
| Nov 8, 2022 | -$ 0.27 | -$ 0.32 | -$ 0.26 | |
| Aug 2, 2022 | -$ 0.24 | -$ 0.38 | -$ 0.27 | |
| May 10, 2022 | -$ 0.41 | -$ 0.27 | $ 0.19 | |
| Mar 3, 2022 | -$ 0.20 | -$ 0.29 | -$ 0.73 |
Evolus’s stock was trading at $ 7.37 on Nov 3, 2026 a day before the last earnings report was released.Following the release of the earnings report, EOLS’s price decreased to $ 6.80 on Nov 5, 2026, recording a
| Report Date | EPS | Price 1 Day Before | Price 1 Day After | Change |
|---|---|---|---|---|
| Nov 4, 2026 | -$ 0.09 | $ 7.37 | $ 6.80 | |
| Aug 5, 2026 | $ 0.00743 | $ 6.12 | $ 7.41 | |
| May 4, 2026 | -$ 0.10 | $ 5.33 | $ 6.37 | |
| Mar 3, 2026 | $ 0.04422 | $ 4.29 | $ 5.59 | |
| Nov 5, 2025 | -$ 0.14 | $ 6.41 | $ 7.18 | |
| Aug 5, 2025 | -$ 0.24 | $ 9.11 | $ 6.37 | |
| May 7, 2025 | -$ 0.18 | $ 11.61 | $ 10.09 | |
| Mar 4, 2025 | $ 0.01 | $ 14.34 | $ 14.17 | |
| Nov 6, 2024 | -$ 0.19 | $ 16.49 | $ 14.29 | |
| Jul 31, 2024 | -$ 0.07 | $ 12.19 | $ 14.04 | |
| May 7, 2024 | -$ 0.13 | $ 13.39 | $ 13.26 | |
| Mar 7, 2024 | -$ 0.14 | $ 14.11 | $ 14.07 | |
| Nov 7, 2023 | -$ 0.19 | $ 7.97 | $ 8.74 | |
| Aug 2, 2023 | -$ 0.22 | $ 10.17 | $ 10.05 | |
| May 9, 2023 | -$ 0.17 | $ 8.93 | $ 10.52 | |
| Mar 8, 2023 | -$ 0.16 | $ 9.17 | $ 8.58 | |
| Nov 8, 2022 | -$ 0.32 | $ 7.72 | $ 7.07 | |
| Aug 2, 2022 | -$ 0.38 | $ 13.11 | $ 9.58 | |
| May 10, 2022 | -$ 0.27 | $ 10.22 | $ 11.16 | |
| Mar 3, 2022 | -$ 0.29 | $ 9.36 | $ 9.53 |
Evolus released its most recent earnings reports in November 2026, August 2026, May 2026, March 2026 respectively. Generally, most companies have a consistent schedule for their earnings releases. However, companies do not necessarily release their earnings reports at the same time each year. The timing of earnings releases can vary depending on a company's fiscal year, industry norms, and internal reporting practices.
Evolus missed analysts’ expectations during the last earnings period by
